Thomas Bures
2023
In 2023, Thomas Bures earned a total compensation of $729K as Senior Vice President and Chief Financial Officer at Pieris Pharmaceuticals, a 23% decrease compared to previous year.
Compensation breakdown
| Bonus | $80,031 |
|---|---|
| Option Awards | $241,536 |
| Salary | $400,155 |
| Other | $7,315 |
| Total | $729,037 |
Bures received $400.2K in salary, accounting for 55% of the total pay in 2023.
Bures also received $80K in bonus, $241.5K in option awards and $7.3K in other compensation.
Rankings
In 2023, Thomas Bures' compensation ranked 1,562nd out of 2,983 executives tracked by ExecPay. In other words, Bures earned more than 47.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,562 out of 2,983 | 48th |
Division Manufacturing | 914 out of 1,637 | 44th |
Major group Chemicals And Allied Products | 589 out of 906 | 35th |
Industry group Drugs | 573 out of 869 | 34th |
Industry Pharmaceutical Preparations | 408 out of 627 | 35th |
Source: SEC filing on November 6, 2024.
Bures' colleagues
We found two more compensation records of executives who worked with Thomas Bures at Pieris Pharmaceuticals in 2023.